Regulus Therapeutics Inc (RGLS)
2.65
-0.04
(-1.49%)
USD |
NASDAQ |
May 03, 16:00
2.65
0.00 (0.00%)
After-Hours: 20:00
Regulus Therapeutics Total Return Price: 2.65 for May 3, 2024
Total Return Price Chart
Historical Total Return Price Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.65 |
| May 02, 2024 | 2.69 |
| May 01, 2024 | 2.51 |
| April 30, 2024 | 2.30 |
| April 29, 2024 | 2.52 |
| April 26, 2024 | 2.42 |
| April 25, 2024 | 2.27 |
| April 24, 2024 | 2.22 |
| April 23, 2024 | 2.26 |
| April 22, 2024 | 2.20 |
| April 19, 2024 | 2.13 |
| April 18, 2024 | 2.22 |
| April 17, 2024 | 2.34 |
| April 16, 2024 | 2.56 |
| April 15, 2024 | 2.78 |
| April 12, 2024 | 2.80 |
| April 11, 2024 | 2.78 |
| April 10, 2024 | 2.62 |
| April 09, 2024 | 2.70 |
| April 08, 2024 | 2.67 |
| April 05, 2024 | 2.54 |
| April 04, 2024 | 2.52 |
| April 03, 2024 | 2.61 |
| April 02, 2024 | 2.72 |
| April 01, 2024 | 2.80 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.88 |
| March 27, 2024 | 2.88 |
| March 26, 2024 | 2.845 |
| March 25, 2024 | 2.82 |
| March 22, 2024 | 2.685 |
| March 21, 2024 | 2.78 |
| March 20, 2024 | 2.50 |
| March 19, 2024 | 2.385 |
| March 18, 2024 | 2.36 |
| March 15, 2024 | 2.11 |
| March 14, 2024 | 2.445 |
| March 13, 2024 | 2.43 |
| March 12, 2024 | 2.36 |
| March 11, 2024 | 1.38 |
| March 08, 2024 | 1.39 |
| March 07, 2024 | 1.42 |
| March 06, 2024 | 1.50 |
| March 05, 2024 | 1.48 |
| March 04, 2024 | 1.49 |
| March 01, 2024 | 1.49 |
| February 29, 2024 | 1.47 |
| February 28, 2024 | 1.49 |
| February 27, 2024 | 1.505 |
| February 26, 2024 | 1.42 |
| February 23, 2024 | 1.46 |
Total Return Price Definition
The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.
Total Return Price Range, Past 5 Years
0.7929
Minimum
Mar 27 2023
19.60
Maximum
Mar 12 2021
5.290
Average
4.464
Median
Sep 08 2020
Total Return Price Benchmarks
| ACADIA Pharmaceuticals Inc | 17.05 |
| ADMA Biologics Inc | 6.81 |
| FibroGen Inc | 1.14 |
| Protara Therapeutics Inc | 2.91 |
| Amylyx Pharmaceuticals Inc | 2.03 |